The UTSW research revealed that exclusive GLP-1RA use among those treated for obesity in this age group rose from 88.2% between May and November in 2022 to 96.1% between June 2025 and January 2026
For a broader understanding of the differences between 503A compounding pharmacies, 503B outsourcing facilities, and generic drug manufacturers, we recommend the excellent article FDA oversight of drug manufacturing and compounding: A comparison by Marta E
Weeks 58: Adjusting to the Therapy As your body acclimates to the medication, your provider may suggest increasing the dose gradually to maximize benefits
Most respondents were employed, with 65% working full-time and 18% employed part-time
Wegovy has shown great success in helping people manage their weight
TrimRX makes access easier by providing telehealth consultations, tailored dosing, unlimited check-ins, and free home delivery ensuring your medication and nutritional support fit seamlessly into your care plan